Document is current
Any future updates will be listed below
-
Authors
Damianos, John A. https://orcid.org/0000-0002-2197-4977
King, Katherine S.
Lee, Alex
Murray, Joseph A.
Bledsoe, Adam C.
- License Information
-
More Information
Article History
Received: 14 August 2025
Accepted: 9 February 2026
First Online: 6 May 2026
Competing interests
: Disclosures: J.A.D. receives clinical trial research funding from ExeGi Pharma. J.A.D. receives consulting fees from ExeGi Pharma and Speakers Bureau fees from i-Health. J.A.M. has received research grants from Nexpep/ImmusanT, National Institutes of Health, Immunogenix, Takeda Pharmaceutical, Allakos, ProventionBio, Oberkotter Foundation, and 9 m, Inc.; contract (to institution) from Kanyos Bio (a wholly owned subsidiary of Anokion); and consultancy fees from Johnson and Johnson, Bristol Myers Squibb, Intrexon Corporation, Dren Bio, Neoleukin, Reistone pharma, Immunic Therapeutics, Senda Biosciences, Brightseed Bio, Chugai Pharma, Alimentiv, Equillium, Ukko, Vial Health Technologies and has received royalties from Torax Medical and Evelo.
